Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation.

Zuñiga Cisneros J, Stehlik J, Selzman CH, Drakos SG, McKellar SH, Wever-Pinzon O.

Circ Heart Fail. 2018 Mar;11(3):e004378. doi: 10.1161/CIRCHEARTFAILURE.117.004378.

PMID:
29664404
2.

Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study.

Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007117. doi: 10.1161/CIRCIMAGING.117.007117.

PMID:
29653930
3.

The Heart Transplant Waiting List and the Interplay of Policy and Practice: In Search of Fairness.

Stehlik J, Wever-Pinzon O.

Circ Heart Fail. 2017 Dec;10(12). pii: e004657. doi: 10.1161/CIRCHEARTFAILURE.117.004657. No abstract available.

PMID:
29246898
4.

Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.

Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos SG.

Eur J Heart Fail. 2018 Jan;20(1):164-174. doi: 10.1002/ejhf.1018. Epub 2017 Nov 1.

PMID:
29094485
5.

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.

Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader F.

ASAIO J. 2018 Jan/Feb;64(1):38-42. doi: 10.1097/MAT.0000000000000614.

PMID:
28661912
6.

The Continuing Quest to Identify Ambulatory Patients With Advanced Heart Failure Who Benefit From Left Ventricular Assist Device Therapy.

Wever-Pinzon O, Drakos SG.

Circ Heart Fail. 2016 Nov;9(11). pii: e003641. No abstract available.

7.

Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.

Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos SG.

J Am Coll Cardiol. 2016 Oct 18;68(16):1741-1752. doi: 10.1016/j.jacc.2016.07.756.

8.

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.

Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH.

J Am Coll Cardiol. 2016 Oct 4;68(14):1540-53. doi: 10.1016/j.jacc.2016.07.743.

9.

Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.

Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, Selzman CH, Fang JC, Lund LH, Stehlik J.

J Heart Lung Transplant. 2017 Apr;36(4):407-417. doi: 10.1016/j.healun.2016.08.008. Epub 2016 Aug 20.

PMID:
27686602
10.

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.

Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J; Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program.

J Heart Lung Transplant. 2016 Aug;35(8):1024-30. doi: 10.1016/j.healun.2016.05.001. Epub 2016 May 6.

PMID:
27316382
11.

Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow.

Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos SG.

JACC Heart Fail. 2016 Jul;4(7):570-576. doi: 10.1016/j.jchf.2016.02.015. Epub 2016 May 11.

12.

National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.

Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, Mancini DM, Colombo P, Topkara VK.

J Heart Lung Transplant. 2016 Jul;35(7):884-92. doi: 10.1016/j.healun.2016.02.004. Epub 2016 Mar 11.

PMID:
27151597
13.

Dealing With Unintended Consequences: Continuous-Flow LVADs and Aortic Insufficiency.

Fang JC, Wever-Pinzon O.

JACC Cardiovasc Imaging. 2016 Jun;9(6):652-4. doi: 10.1016/j.jcmg.2015.07.016. Epub 2015 Dec 9. No abstract available.

14.

Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database.

Pan S, Aksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, Fried JA, Takeda K, Hiroo T, Yuzefpolskaya M, Uriel N, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK.

J Heart Lung Transplant. 2015 Dec;34(12):1624-9. doi: 10.1016/j.healun.2015.08.004. Epub 2015 Sep 1.

PMID:
26442678
15.

Team-based Care for Advanced Heart Failure.

Wever-Pinzon O, Drakos SG, Fang JC.

Heart Fail Clin. 2015 Jul;11(3):467-77. doi: 10.1016/j.hfc.2015.03.009. Review.

PMID:
26142642
16.

Non-invasive assessment of low risk acute chest pain in the emergency department: A comparative meta-analysis of prospective studies.

Romero J, Husain SA, Holmes AA, Kelesidis I, Chavez P, Mojadidi MK, Levsky JM, Wever-Pinzon O, Taub C, Makani H, Travin MI, Piña IL, Garcia MJ.

Int J Cardiol. 2015;187:565-80. doi: 10.1016/j.ijcard.2015.01.032. Epub 2015 Jan 22.

PMID:
25863305
17.

Early power elevations and adverse events with the HeartMate II left ventricular assist device: An unsettled issue.

Wever-Pinzon O, Jorde UP.

J Heart Lung Transplant. 2014 Nov;33(11):1200-1. doi: 10.1016/j.healun.2014.09.003. Epub 2014 Sep 10. No abstract available.

PMID:
25438166
18.

Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon.

Wever-Pinzon O, Givens RC, Flannery M, Naka Y, Jorde UP.

J Heart Lung Transplant. 2015 Feb;34(2):270-1. doi: 10.1016/j.healun.2014.09.048. Epub 2014 Oct 24. No abstract available.

19.

Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG.

J Am Coll Cardiol. 2014 Oct 14;64(15):1602-12. doi: 10.1016/j.jacc.2014.05.073.

20.

Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.

Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW.

NMR Biomed. 2014 Nov;27(11):1378-86. doi: 10.1002/nbm.3200. Epub 2014 Sep 9.

21.

Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials.

Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Piña IL, Kfoury AG, Garcia MJ, Stehlik J.

J Am Coll Cardiol. 2014 May 20;63(19):1992-2004. doi: 10.1016/j.jacc.2014.01.071. Epub 2014 Mar 26.

PMID:
24681148
22.

Reply: left ventricular assist devices in chronic heart failure: more questions than answers?

Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos SG.

J Am Coll Cardiol. 2013 Dec 10;62(23):2257-8. doi: 10.1016/j.jacc.2013.08.713. Epub 2013 Sep 4. No abstract available.

23.

CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials.

Romero J, Kahan J, Kelesidis I, Makani H, Wever-Pinzon O, Medina H, Garcia MJ.

Eur Heart J Cardiovasc Imaging. 2013 Nov;14(11):1080-91. doi: 10.1093/ehjci/jet040. Epub 2013 Apr 10. Review.

PMID:
23575990
24.

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG; UCAR (Utah Cardiac Recovery Program) Investigators.

J Am Coll Cardiol. 2013 May 14;61(19):1985-94. doi: 10.1016/j.jacc.2013.01.072. Epub 2013 Mar 14.

25.

Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F.

Circ Heart Fail. 2013 May;6(3):517-26. doi: 10.1161/CIRCHEARTFAILURE.112.000206. Epub 2013 Mar 11.

26.

Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?

Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J.

Circulation. 2013 Jan 29;127(4):452-62. doi: 10.1161/CIRCULATIONAHA.112.100123. Epub 2012 Dec 27.

27.

Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.

Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, Bangalore S.

Am J Cardiol. 2012 Aug 1;110(3):383-91. doi: 10.1016/j.amjcard.2012.03.034. Epub 2012 Apr 20.

PMID:
22521308
28.

Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.

Wever-Pinzon O, Suma V, Ahuja A, Romero J, Sareen N, Henry SA, De Benedetti Zunino M, Chaudhry FF, Suryadevara RS, Sherrid MV, Chaudhry FA.

Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):857-62. doi: 10.1093/ehjci/jes057. Epub 2012 Mar 16.

29.

Ventricular assist devices: pharmacological aspects of a mechanical therapy.

Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG.

Pharmacol Ther. 2012 May;134(2):189-99. doi: 10.1016/j.pharmthera.2012.01.003. Epub 2012 Jan 16. Review.

30.

Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy.

Wever-Pinzon O, Romero J, Cordova JP.

Am J Ther. 2013 Sep-Oct;20(5):588-90. doi: 10.1097/MJT.0b013e31821109ff.

31.

Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study.

Wever-Pinzon O, Bangalore S, Romero J, Silva Enciso J, Chaudhry FA.

JACC Cardiovasc Imaging. 2011 Dec;4(12):1231-8. doi: 10.1016/j.jcmg.2011.09.012.

32.

Arterial embolism caused by large mobile aortic thrombus in the absence of atherosclerosis, associated with iron deficiency anemia.

Bukharovich IF, Wever-Pinzon O, Shah A, Todd G, Chaudhry FA, Sherrid MV.

Echocardiography. 2012 Mar;29(3):369-72. doi: 10.1111/j.1540-8175.2011.01606.x. Epub 2011 Dec 9. No abstract available.

33.

Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease.

Yao SS, Wever-Pinzon O, Zhang X, Bangalore S, Chaudhry FA.

Am J Cardiol. 2012 Jan 15;109(2):153-8. doi: 10.1016/j.amjcard.2011.08.023. Epub 2011 Oct 21.

34.

PDE3 inhibition in dilated cardiomyopathy.

Movsesian M, Wever-Pinzon O, Vandeput F.

Curr Opin Pharmacol. 2011 Dec;11(6):707-13. doi: 10.1016/j.coph.2011.09.001. Epub 2011 Sep 28. Review.

35.

Impact of donor left ventricular hypertrophy on survival after heart transplant.

Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J.

Am J Transplant. 2011 Dec;11(12):2755-61. doi: 10.1111/j.1600-6143.2011.03744.x. Epub 2011 Sep 11.

36.

Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography.

Wever Pinzon O, Silva Enciso J, Romero J, Makani H, Fefer J, Gandhi V, Bangalore S, Chaudhry FA.

Circ Cardiovasc Imaging. 2011 Jul;4(4):363-70. doi: 10.1161/CIRCIMAGING.110.961060. Epub 2011 Jul 12.

37.

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.

Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH.

Am J Med. 2011 Feb;124(2):128-35. doi: 10.1016/j.amjmed.2010.08.007.

PMID:
21295192
38.

Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies.

Supariwala A, Uretsky S, Singh P, Memon S, Khokhar SS, Wever-Pinzon O, Atluri P, Hersh J, Koppuravuri HK, Rozanski A.

J Nucl Cardiol. 2011 Apr;18(2):207-14; quiz 217. doi: 10.1007/s12350-010-9330-3. Epub 2010 Dec 24.

PMID:
21184207
39.

Recurrent Takotsubo cardiomyopathy presenting with different morphologic patterns.

Wever-Pinzon O, Wever-Pinzon J, Tami L.

Int J Cardiol. 2011 May 5;148(3):379-81. doi: 10.1016/j.ijcard.2010.10.091. Epub 2010 Dec 15. No abstract available.

PMID:
21109319
40.

Takotsubo cardiomyopathy following a blood transfusion.

Wever-Pinzon O, Tami L.

Congest Heart Fail. 2010 May-Jun;16(3):129-31. doi: 10.1111/j.1751-7133.2009.00134.x. No abstract available.

41.

Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities.

Wever-Pinzon OE, Myerson M, Sherrid MV.

Anadolu Kardiyol Derg. 2009 Dec;9 Suppl 2:17-23.

42.

Reflections of inflections in hypertrophic cardiomyopathy.

Sherrid MV, Wever-Pinzon O, Shah A, Chaudhry FA.

J Am Coll Cardiol. 2009 Jul 14;54(3):212-9. doi: 10.1016/j.jacc.2009.03.052. Review.

Supplemental Content

Loading ...
Support Center